Drug therapy of cardiogenic shock.
D002301:Cardiac Glycosides / Q000627:therapeutic use; D002302:Cardiac Output; D006801:Humans; D009206:Myocardium / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects; D012770:Shock, Cardiogenic / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D013566:Sympathomimetics / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D002301:Cardiac Glycosides; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents